Cleared Traditional

K223101 - BD Secondary Infusion Set

K223101 is an FDA 510(k) clearance for BD Secondary Infusion Set, manufactured by Care Fusion. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 224-day FDA review.

K223101 · Care Fusion · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2023
Decision
224d
Days
Class 2
Risk

K223101 is an FDA 510(k) clearance for the BD Secondary Infusion Set. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Care Fusion (San Diego, US). The FDA issued a Cleared decision on May 12, 2023 after a review of 224 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Care Fusion devices

FDA 510(k) Submission Details - K223101

510(k) Number K223101 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2022
Decision Date May 12, 2023
Days to Decision 224 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d slower than avg
Panel avg: 129d · This submission: 224d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 769
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K223101.
DJF Intravascular Administration Set
K230992 · Yangzhou Wei DE LI Trade Co., Ltd. · Jun 2023
Volumat Line
K220301 · Fresenius Kabi · Jun 2023
I.V. Administration Set, I.V. Extension Set
K223645 · Bq Plus Medical Co., Ltd. · May 2023
NP Medical nPulse K150 Neutral Displacement Needle Free Connector, nPulse Neutral displacement needle free connector, nPulse K150 Needle Free Connector
K220288 · Np Medical, Inc. · Apr 2023
Polyfusion IV Administration Sets
K220312 · Poly Medicure Limited · Apr 2023
BD SmartSite™ Needle-Free Connector
K223088 · Care Fusion · Apr 2023